Lora B. Kramer
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Cell death mechanisms and regulation
- Sphingolipid Metabolism and Signaling
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 6
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
-
- Cell death mechanisms and regulation 4
- Protein Kinase Regulation and GTPase Signaling 1
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Steven Grant (25 shared papers)Yun Dai (18 shared papers)Paul Dent (18 shared papers)Shuang Chen (10 shared papers)Mohamed Rahmani (6 shared papers)W. David Jarvis (3 shared papers)Xin‐Yan Pei (7 shared papers)Jorge A. Almenara (3 shared papers)
- Journals
- Blood (7 papers)Biochemical Pharmacology (3 papers)Clinical Cancer Research (3 papers)Cancer Research (3 papers)Molecular Pharmacology (3 papers)
- Partner nations
- United StatesChina
In The Last Decade
Lora B. Kramer
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 51
- Hematology 157
- Molecular Biology 478
- Pharmacology 41
- Oncology 58
- Genetics 25
Countries citing papers authored by Lora B. Kramer
This map shows the geographic impact of Lora B. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora B. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora B. Kramer more than expected).
Fields of papers citing papers by Lora B. Kramer
This network shows the impact of papers produced by Lora B. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora B. Kramer. The network helps show where Lora B. Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lora B. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 127 | |
| 2 | 2004 | 117 | |
| 3 | 2008 | 90 | |
| 4 | 2011 | 74 | |
| 5 | 2004 | 73 | |
| 6 | 2008 | 73 | |
| 7 | 1997 | 71 | |
| 8 | 2011 | 59 | |
| 9 | 2009 | 48 | |
| 10 | 2012 | 48 | |
| 11 | 2006 | 40 | |
| 12 | 2011 | 39 | |
| 13 | 2011 | 35 | |
| 14 | 1995 | 33 | |
| 15 | 1992 | 32 | |
| 16 | 2009 | 30 | |
| 17 | 1988 | 26 | |
| 18 | 1996 | 26 | |
| 19 | Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia. | 2002 | 26 |
| 20 | 2014 | 26 |
About Lora B. Kramer
Lora B. Kramer is a scholar working on Hematology, Molecular Biology, Genetics, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Cell death mechanisms and regulation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer-related Molecular Pathways (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (157 citations), Molecular Biology (478 citations), Pharmacology (41 citations), Oncology (58 citations) and Genetics (25 citations). Lora B. Kramer has collaborated with scholars based in United States and China. Frequent co-authors include Steven Grant, Yun Dai, Paul Dent, Shuang Chen, Mohamed Rahmani, W. David Jarvis, Xin‐Yan Pei, Jorge A. Almenara, Charles O. Watlington and Heather A. Martin. Their work appears in journals such as Blood, Biochemical Pharmacology, Clinical Cancer Research, Cancer Research and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.